Uvre Limited
Uvre Limited (UVA.AX) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Uvre Limited (UVA.AX), featuring income statements, balance sheets, and cash flow data.
Uvre Limited (UVA.AX) Income Statement & Financial Overview
View the income breakdown for Uvre Limited UVA.AX across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $245.00 | $245.00 | $382.00 | $382.00 |
| Operating Expenses | $245.00 | $245.00 | $382.00 | $395.00 |
| Total Costs & Expenses | $245.00 | $245.00 | $382.00 | $395.00 |
| Interest Income | $0.00 | $0.00 | $25.00 | $25.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $245.00 | $245.00 | $382.00 | $382.00 |
| EBITDA | $0.00 | $0.00 | $13.00 | $13.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$245.00 | -$245.00 | -$382.00 | -$382.00 |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$8.00 | -$8.00 | $13.00 | $13.00 |
| Income Before Tax | -$253.00 | -$253.00 | -$370.00 | -$370.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $13.00 | $13.00 |
| Net Income | -$253.00 | -$253.00 | -$370.00 | -$370.00 |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | $0.00 | -$0.006 | -$0.009 | -$0.009 |
| Diluted EPS | $0.00 | -$0.006 | -$0.009 | -$0.009 |
| Weighted Avg Shares Outstanding | $43.88M | $43.88M | $40.98M | $40.98M |
| Weighted Avg Shares Outstanding (Diluted) | $44.05M | $44.05M | $40.97M | $40.97M |
Over the past four quarters, Uvre Limited demonstrated steady revenue growth, increasing from $0.00 in Q1 2024 to $0.00 in Q4 2024. Operating income reached -$245.00 in Q4 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $0.00, reflecting operational efficiency. Net income rose to -$253.00, with EPS at $0.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan